Tianjin Chase Sun Pharmaceutical Co., Ltd. logo

Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026)

Market Closed
16 Oct, 07:00 AM
XSHE XSHE
¥
3. 20
-0.02
-0.6211%
¥
11.18B Market Cap
- P/E Ratio
0.12% Div Yield
98.02M Volume
- Eps
¥ 3.22
Previous Close
Add Transaction
Day Range
3.18 3.31
Year Range
2.82 3.99
Want to track 300026 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026) Statistics

Valuation metrics

Market Cap 11.18B
Enterprise value 8.72B
Trailing P/E (ttm) 790.48
Forward P/E -
PEG ratio -31.7
Price/Sales (ttm) 2.3
Price/Book (mrq) 1.17
Enterprise Value/Revenue 2.01
Enterprise Value/EBITDA 23.88

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 49.65M
Average volume (90 days) 68.37M

Price summary

52-Week low 2.82
52-Week high 3.99
Beta -
50-Day moving average 3.3
200-Day moving average 3.33

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.01
Trailing annual dividend yield 0.003%
5-Year annual dividend yield -
Payout ratio 5.18
Dividend Date 15 Jul 2026
Ex-Dividend Date 15 Jul 2026
Last split factor 30:10
Last split Date 26 Oct 2016

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0%
Operating margin 0.04%

Operational effectiveness

Return on assets 0%
Return on equity 0%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.44
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.01
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 4.37%
Book value per share (mrq) 2.89

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -